Genetic factors associated to development of thrombocytopenia in preeclampsia.

Preeclampsia is a hypertensive disease that occurs after the 20 weeks of pregnancy, it is characterized by causing damage to various organs of the human body, mainly the liver and kidney, for this reason, it will be evidenced in laboratory tests: proteinuria, increased liver enzymes, hemolysis, olig...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2022
Institución:
Pontificia Universidad Javeriana Cali
Repositorio:
Vitela
Idioma:
spa
OAI Identifier:
oai:vitela.javerianacali.edu.co:11522/441
Acceso en línea:
https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634
https://vitela.javerianacali.edu.co/handle/11522/441
Palabra clave:
Trombocitopenia
Preeclampsia
Genética
Megacariopoyesis
Thrombocytopenia
Preeclampsia
Genetic
Megakaryopoiesis
Rights
License
Derechos de autor 2022 Salutem Scientia Spiritus
id Vitela2_f28008120fe27df5faba367bd9f24958
oai_identifier_str oai:vitela.javerianacali.edu.co:11522/441
network_acronym_str Vitela2
network_name_str Vitela
repository_id_str
spelling Córdoba-García, Santiago2022-12-232023-10-11T04:34:53Z2023-10-11T04:34:53Zhttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634https://vitela.javerianacali.edu.co/handle/11522/441Preeclampsia is a hypertensive disease that occurs after the 20 weeks of pregnancy, it is characterized by causing damage to various organs of the human body, mainly the liver and kidney, for this reason, it will be evidenced in laboratory tests: proteinuria, increased liver enzymes, hemolysis, oliguria, increased creatinine levels, thrombocytopenia, etc. The finding of thrombocytopenia during pregnancy always raises concern for clinicians due largely to the multiplicity of etiologies that must be considered to make a diagnosis. This topic review aims to analyze the presence of genetic factors that predispose or influence the development of thrombocytopenia in women with preeclampsia, highlighting to the reader the importance of prenatal controls in the prevention of diseases in pregnancy, keeping in mind risk factors associated with the development of pathologies in maternal and carry out the appropriate treatment to avoid complications in the gestation period. A literature search was conducted in the MedLine (PubMed), Clinical Key, and Science Direct databases, without restriction in time or language, considering the articles that described the diagnostic aspects, the genetic factors involved in the development of thrombocytopenia in preeclampsia, obtaining 57 articles after their selection process.La preeclampsia es una enfermedad hipertensiva que ocurre después de la semana 20 del embarazo, se caracteriza por causar daños en varios órganos del cuerpo humano, principalmente en el hígado y riñón, en razón a ello se evidenciara en los exámenes de laboratorio: proteinuria, aumento de las enzimas hepáticas, hemolisis, oliguria, aumento de los niveles de creatinina, trombocitopenia, etc. El hallazgo de una trombocitopenia durante la gestación siempre genera preocupación al personal clínico debido en gran parte a la multiplicidad de etiologías que se deben considerar para realizar un diagnóstico. En esta revisión de tema tiene como objetivo analizar la presencia de factores genéticos que predispones o influyen en el desarrollo de la trombocitopenia en mujeres con preeclampsia, destacándole al lector la importancia que tienen los controles prenatales en la prevención de enfermedades en el embarazo, tener presente factores de riegos asociados al desarrollo de patologías en las maternas y realiza el tratamiento oportuno para evitar complicaciones en el periodo de gestación. Se realizó una búsqueda en la literatura en las bases de datos MedLine (PubMed), Clinical Key y Science Direct, sin restricción en tiempo ni idioma, teniendo en cuenta los artículos que describieran los aspectos diagnósticos, los factores genéticos implicados en el desarrollo de trombocitopenia en la preeclampsia, obteniendo 57 artículos después del proceso de selección de los mismos.application/pdfspaPontificia Universidad Javeriana Calihttps://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634/537Derechos de autor 2022 Salutem Scientia Spiritushttps://creativecommons.org/licenses/by-nc-nd/4.0Salutem Scientia Spiritus; Vol. 8 No. 4 (2022): Revista Salutem Scientia Spiritus; 77-83Salutem Scientia Spiritus; Vol. 8 Núm. 4 (2022): Revista Salutem Scientia Spiritus; 77-832463-1426TrombocitopeniaPreeclampsiaGenéticaMegacariopoyesisThrombocytopeniaPreeclampsiaGeneticMegakaryopoiesisGenetic factors associated to development of thrombocytopenia in preeclampsia.Factores genéticos asociados al desarrollo de trombocitopenia en la preeclampsia.info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionRevisión de la literatura11522/441oai:vitela.javerianacali.edu.co:11522/4412024-06-25 05:12:42.271metadata.onlyhttps://vitela.javerianacali.edu.coRepositorio Vitelavitela.mail@javerianacali.edu.co
dc.title.en-US.fl_str_mv Genetic factors associated to development of thrombocytopenia in preeclampsia.
dc.title.es-ES.fl_str_mv Factores genéticos asociados al desarrollo de trombocitopenia en la preeclampsia.
title Genetic factors associated to development of thrombocytopenia in preeclampsia.
spellingShingle Genetic factors associated to development of thrombocytopenia in preeclampsia.
Córdoba-García, Santiago
Trombocitopenia
Preeclampsia
Genética
Megacariopoyesis
Thrombocytopenia
Preeclampsia
Genetic
Megakaryopoiesis
title_short Genetic factors associated to development of thrombocytopenia in preeclampsia.
title_full Genetic factors associated to development of thrombocytopenia in preeclampsia.
title_fullStr Genetic factors associated to development of thrombocytopenia in preeclampsia.
title_full_unstemmed Genetic factors associated to development of thrombocytopenia in preeclampsia.
title_sort Genetic factors associated to development of thrombocytopenia in preeclampsia.
dc.creator.none.fl_str_mv Córdoba-García, Santiago
author Córdoba-García, Santiago
author_facet Córdoba-García, Santiago
author_role author
dc.subject.es-ES.fl_str_mv Trombocitopenia
Preeclampsia
Genética
Megacariopoyesis
topic Trombocitopenia
Preeclampsia
Genética
Megacariopoyesis
Thrombocytopenia
Preeclampsia
Genetic
Megakaryopoiesis
dc.subject.en-US.fl_str_mv Thrombocytopenia
Preeclampsia
Genetic
Megakaryopoiesis
description Preeclampsia is a hypertensive disease that occurs after the 20 weeks of pregnancy, it is characterized by causing damage to various organs of the human body, mainly the liver and kidney, for this reason, it will be evidenced in laboratory tests: proteinuria, increased liver enzymes, hemolysis, oliguria, increased creatinine levels, thrombocytopenia, etc. The finding of thrombocytopenia during pregnancy always raises concern for clinicians due largely to the multiplicity of etiologies that must be considered to make a diagnosis. This topic review aims to analyze the presence of genetic factors that predispose or influence the development of thrombocytopenia in women with preeclampsia, highlighting to the reader the importance of prenatal controls in the prevention of diseases in pregnancy, keeping in mind risk factors associated with the development of pathologies in maternal and carry out the appropriate treatment to avoid complications in the gestation period. A literature search was conducted in the MedLine (PubMed), Clinical Key, and Science Direct databases, without restriction in time or language, considering the articles that described the diagnostic aspects, the genetic factors involved in the development of thrombocytopenia in preeclampsia, obtaining 57 articles after their selection process.
publishDate 2022
dc.date.accessioned.none.fl_str_mv 2023-10-11T04:34:53Z
dc.date.available.none.fl_str_mv 2023-10-11T04:34:53Z
dc.date.none.fl_str_mv 2022-12-23
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
dc.type.es-ES.fl_str_mv Revisión de la literatura
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634
dc.identifier.uri.none.fl_str_mv https://vitela.javerianacali.edu.co/handle/11522/441
url https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634
https://vitela.javerianacali.edu.co/handle/11522/441
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/634/537
dc.rights.es-ES.fl_str_mv Derechos de autor 2022 Salutem Scientia Spiritus
https://creativecommons.org/licenses/by-nc-nd/4.0
rights_invalid_str_mv Derechos de autor 2022 Salutem Scientia Spiritus
https://creativecommons.org/licenses/by-nc-nd/4.0
dc.format.none.fl_str_mv application/pdf
dc.publisher.es-ES.fl_str_mv Pontificia Universidad Javeriana Cali
dc.source.en-US.fl_str_mv Salutem Scientia Spiritus; Vol. 8 No. 4 (2022): Revista Salutem Scientia Spiritus; 77-83
dc.source.es-ES.fl_str_mv Salutem Scientia Spiritus; Vol. 8 Núm. 4 (2022): Revista Salutem Scientia Spiritus; 77-83
dc.source.none.fl_str_mv 2463-1426
institution Pontificia Universidad Javeriana Cali
repository.name.fl_str_mv Repositorio Vitela
repository.mail.fl_str_mv vitela.mail@javerianacali.edu.co
_version_ 1808493687114563584